☆ 4.7 Article

Targeting the chromatin remodeling protein BRG1 in liver fibrosis: Mechanism and translational potential

LIFE SCIENCES (2024)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, Research & Experimental

Targetable Brg1-CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking

Nan Li et al.

Summary: In this study, we found that the Brg1 gene plays a crucial role in the development of alcoholic liver disease (ALD) and has potential implications for ALD intervention. Brg1 expression was increased in ALD mouse models, alcohol-exposed hepatocytes, and human ALD specimens. Manipulation of Brg1 expression in hepatocytes affected ALD development in mice. The deficiency of Brg1 specifically attenuated hepatic infiltration of Ly6G(+) neutrophils in ALD mice. Furthermore, the study identified CXCL14 as a potential target for Brg1, and manipulation of CXCL14 expression affected ALD pathogenesis.

EMBO MOLECULAR MEDICINE (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease

Huan Wang et al.

Summary: Phospholipase D1 (PLD1) plays a crucial role in hepatocyte lipid metabolism and may be involved in non-alcoholic fatty liver disease (NAFLD). Inhibition of hepatocyte PLD1 shows potential benefits in attenuating hepatic steatosis and could be a novel target for NAFLD treatment.

JHEP REPORTS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling

Wantong Su et al.

Summary: This study reveals that hepatocyte ferroptosis regulates macrophage STING activation, which promotes liver damage, fibrosis, and tumorigenesis. Inhibition of macrophage STING signaling can alleviate liver injury, fibrosis, and tumor burden, suggesting it as a potential therapeutic approach for chronic liver diseases.

JHEP REPORTS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

C-C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease

Zhiwen Fan et al.

Summary: This study found that CCL11 plays a regulatory role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Inhibition or knockout of CCL11 can attenuate the pathological changes of NAFLD, including reduced body weight gain, improved insulin sensitivity, decreased lipid accumulation, and weakened liver fibrosis. Additionally, there is a positive correlation between CCL11 expression and NAFLD parameters in human patients.

JHEP REPORTS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Cathelicidin promotes liver repair after acetaminophen-induced liver injury in mice

Tingting Zhai et al.

Summary: This study aimed to test whether cathelicidin (Camp) protects mice against APAP-induced liver injury and ALF. The results showed that Camp promotes liver recovery by facilitating inflammation resolution, suggesting a therapeutic potential for late-presenting patients with AILI with or without ALF.

JHEP REPORTS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis

Benedikt Simbrunner et al.

JHEP Reports (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis

Franziska Schmalz et al.

Summary: The rs13702 variant in the LPL gene is associated with a reduced risk of hepatocellular carcinoma (HCC) in patients with alcohol-associated liver disease (ALD). This variant may serve as a potential marker for stratifying HCC risk in ALD.

JHEP REPORTS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Intestinal Reg4 deficiency confers susceptibility to high-fat diet- induced liver steatosis by increasing intestinal fat absorption in mice

Ying Wang et al.

Summary: Deficiency of REG4 leads to increased intestinal fat absorption and susceptibility to obesity and hepatic steatosis. REG4 administration reduces fat absorption and decreases the expression of proteins related to intestinal fat absorption. These findings suggest that REG4 may provide a potential target for prevention and treatment of liver steatosis in children.

JHEP REPORTS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease

Jingjin Jiao et al.

Summary: This study investigated the relationship between STAT3 activation and liver fibrosis progression in patients with non-alcoholic fatty liver disease (NAFLD). The results showed that STAT3 activation in non-hepatocyte areas was positively correlated with the severity of liver fibrosis. Furthermore, the study found that STAT3 activation was enriched in hepatic progenitor cells (HPCs) and sinusoidal endothelial cells, and inhibiting STAT3 reduced liver fibrosis and decreased the number of HPCs.

JHEP REPORTS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease

Yan Guo et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a contributing factor to the global epidemic of metabolic syndrome and is considered a prelude to end-stage liver diseases. In this study, the involvement of early growth response 1 (Egr1) in NAFLD was investigated, and it was found that Egr1 was upregulated in NAFLD. Further analysis revealed that serum response factor (SRF) mediated Egr1 transactivation. Depletion of Egr1 significantly mitigated NAFLD in mice. These findings identify Egr1 as a novel modulator of NAFLD and a potential target for intervention.

JHEP REPORTS (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression

Martina Mang Leng Lei et al.

Summary: This study reveals that SCYL3 plays a critical role in promoting the progression of hepatocellular carcinoma (HCC). It is often overexpressed in HCC, especially in metastatic tumors, and is associated with worse patient survival. Suppression of SCYL3 attenuates cell proliferation, migration, and in vivo metastasis in HCC.

JHEP REPORTS (2023)

添加到收藏夹

Article Oncology

Myocardin-related transcription factor A drives ROS-fueled expansion of hepatic stellate cells by regulating p38-MAPK signalling

Wenhui Dong et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Article Cell Biology

Trans-activation of eotaxin-1 by Brg1 contributes to liver regeneration

Zhiwen Fan et al.

Summary: Infiltration of eosinophils is associated with and contributes to liver regeneration. Eotaxin-1 expression is elevated in proliferating murine livers and can be stimulated by hepatocyte growth factor (HGF). Brg1 is a chromatin remodeling protein that directly binds to the eotaxin promoter to activate its transcription, and interacts with NF-kappa B/RelA to activate eotaxin transcription. Depletion of eotaxin or Brg1 deficiency delays liver regeneration.

CELL DEATH & DISEASE (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Exercise training after myocardial infarction increases survival but does not prevent adverse left ventricle remodeling and dysfunction in high-fat diet fed mice

Carmem Peres Valgas Da Silva et al.

Summary: This study demonstrates that aerobic exercise can significantly improve survival after myocardial infarction (MI), independent of its effects on cardiac function. However, exercise does not have an impact on obesity and glucose intolerance induced by a high-fat diet (HFD). This highlights the importance of considering environmental interventions, including diet, in the cardiac rehabilitation of obese patients.

LIFE SCIENCES (2022)

添加到收藏夹

Article Hematology

Epigenetic repression of THBD transcription by BRG1 contributes to deep vein thrombosis

Teng Wu et al.

Summary: BRG1 deficiency in endothelial cells significantly reduces susceptibility to DVT, decreases thrombus weight and size, and reduces immune infiltration. BRG1 regulates THBD expression by influencing CpG methylation levels of the THBD promoter through upregulating DNMT1 expression. Administration of BRG1 inhibitor PFI-3 shows potential for DVT prevention and therapy.

THROMBOSIS RESEARCH (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression

Qi Wang et al.

Summary: This study revealed that XBP1 controls macrophage cGAS/STING/NLRP3 activation by regulating cytosolic leakage of macrophage self-mtDNA via BNIP3-mediated mitophagy modulation, providing a novel target against liver fibrosis.

JHEP REPORTS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Acetaminophen-induced reduction of NIMA-related kinase 7 expression exacerbates acute liver injury

Zhenzhen Sun et al.

Summary: This study revealed the important role of NEK7 in acetaminophen-induced acute liver injury. Reduced NEK7 exacerbates liver damage and provides protection against APAP-induced injury by regulating the cell cycle progression.

JHEP REPORTS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Novel role of macrophage TXNIP-mediated CYLD-NRF2-OASL1 axis in stress-induced liver inflammation and cell death

Yongqiang Zhan et al.

Summary: Macrophage TXNIP deficiency enhances CYLD activity and activates the NRF2-OASL1 signaling, controlling oxidative/endoplasmic reticulum stress-induced liver injury. The NRF2-regulated target gene OASL1 plays a crucial role in modulating STING-mediated TBK1 activation and apoptotic/necroptotic cell death pathway.

JHEP REPORTS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Macrophage MerTK promotes profibrogenic cross-talle with hepatic stellate cells via soluble mediators

Mirella Pastore et al.

Summary: Activation of MerTK in macrophages promotes a profibrogenic phenotype in hepatic stellate cells (HSCs), contributing to the pathogenesis of hepatic fibrosis. MerTK signaling induces the production of factors that enhance migration, proliferation, and expression of profibrogenic factors in HSCs.

JHEP REPORTS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis

Christina Nalkurthi et al.

Summary: By administrating a selective ROCK2 inhibitor, the prevention and reversal of hepatic fibrosis can be achieved through its effects on pro-inflammatory immune cell function. This study sheds light on the therapeutic potential of ROCK2 targeting in chronic liver disease and provides insights into the cellular and molecular pathways driving liver fibrosis.

JHEP REPORTS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection

Nicholas van Buuren et al.

Summary: By analyzing liver biopsies from patients with chronic HBV infection using RNA-Seq and a custom multiplex immunofluorescence panel, two distinct liver immune microenvironments were identified as immune high and immune low. Patients with immune high status exhibited elevated immune pathways and increased presence of immune cells.

JHEP REPORTS (2022)

添加到收藏夹

Article Oncology

The Bromodomain Inhibitor PFI-3 Sensitizes Cancer Cells to DNA Damage by Targeting SWI/SNF

Daye Lee et al.

Summary: The study reveals that the PFI-3 inhibitor targeting SWI/SNF can enhance the sensitivity of various human cancer cell lines to DNA damage induced by chemotherapeutic drugs, by directly blocking SWI/SNF's chromatin binding and leading to an increase in cell death pathways.

MOLECULAR CANCER RESEARCH (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Brahma-Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion

Yongjie Zhou et al.

Summary: This study found that high expression of Brg1 is associated with poor prognosis in patients with iCCA, and that Brg1 plays a critical role in promoting HPC expansion, liver fibrosis, and iCCA development, mainly dependent on the Wnt/β-catenin signaling pathway. Targeting Brg1-expressing HPCs may be a promising therapeutic approach for liver cirrhosis and iCCA.

HEPATOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Thyroid hormone mediates cardioprotection against postinfarction remodeling and dysfunction through the IGF-1/PI3K/AKT signaling pathway

Bin Zeng et al.

Summary: The study found that T3 pretreatment significantly reduces myocardial infarct area, inhibits cardiomyocyte apoptosis and fibrosis, and improves left ventricular function post-MI. Furthermore, T3 can also promote angiogenesis, reduce inflammatory cytokines, and protect the heart from damage after MI.

LIFE SCIENCES (2021)

添加到收藏夹

Article Cell Biology

The Chromatin Remodeling Protein BRG1 Regulates SREBP Maturation by Activating SCAP Transcription in Hepatocytes

Ming Kong et al.

Summary: BRG1 deficiency in mice results in reduced processing and nuclear accumulation of SREBP in the liver, affecting lipid metabolism. BRG1 plays a crucial role in regulating SREBP by activating SCAP transcription, ultimately influencing SREBP target gene expression.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Redox-sensitive activation of CCL7 by BRG1 in hepatocytes during liver injury

Ming Kong et al.

Summary: Liver injuries induced by various stimuli lead to an upregulation of CCL7 expression, which plays an important role in macrophage migration during liver injury. This process is regulated by BRG1, which interacts with AP-1 and is phosphorylated by CK2, and this pathway is sensitive to redox changes. This study provides new insights into the mechanisms of liver inflammation and repair.

REDOX BIOLOGY (2021)

添加到收藏夹

Article Cell Biology

Epigenetic Repression of Chloride Channel Accessory 2 Transcription in Cardiac Fibroblast: Implication in Cardiac Fibrosis

Tinghui Shao et al.

Summary: The study investigated the transcriptional regulation mechanism of Clca2 in cardiac fibrosis, revealing that the Twist1-HDAC1 complex can suppress the expression of Clca2 in cardiac fibroblasts, potentially leading to FMyT and cardiac fibrosis.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Article Cell Biology

Dual Regulation of Tank Binding Kinase 1 by BRG1 in Hepatocytes Contributes to Reactive Oxygen Species Production

Fangqiao Lv et al.

Summary: BRG1 deletion led to down-regulation of TBK1 expression and phosphorylation, affecting ROS production. BRG1 not only directly activated TBK1 transcription by interacting with AP-1, but also activated c-SRC transcription by interacting with Sp1, impacting TBK1 phosphorylation.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Nicotinamide mononucleotide attenuates isoproterenol-induced cardiac fibrosis by regulating oxidative stress and Smad3 acetylation

Keke Wu et al.

Summary: Nicotinamide mononucleotide (NMN) can attenuate cardiac fibrosis in vivo and fibroblast activation in vitro by suppressing oxidative stress and Smad3 acetylation in a NAD(+)/SIRT1-dependent manner.

LIFE SCIENCES (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease

Tatyana Masyuk et al.

Summary: The study found that the reduction of miR-345 in PLD cholangiocytes (PLDCs) by autophagy accelerates hepatic cystogenesis. Restoration of miR-345 in PLDCs via inhibition of autophagy decreases hepatic cystogenesis and is beneficial for PLD.

JHEP REPORTS (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatic Stellate Cell Regulation of Liver Regeneration and Repair

Laura J. Kitto et al.

Summary: Mesenchymal cells play a key role during liver regeneration, with recent single-cell genomics approaches revealing spatial and functional zonation of the hepatic mesenchyme in homeostasis and following liver injury. The use of preclinical models helps to precisely identify highly targeted, pro-regenerative therapies for patients with liver disease.

HEPATOLOGY COMMUNICATIONS (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Molecular and cellular mechanisms of liver fibrosis and its regression

Tatiana Kisseleva et al.

Summary: Chronic liver injury results in liver inflammation and fibrosis, which can be reversed by eliminating activated myofibroblasts and resorbing the fibrous scar. Understanding the molecular mechanisms underlying liver fibrosis and its reversibility can lead to the identification of new therapeutic targets for liver fibrosis treatment.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

BRG1 deficiency in endothelial cells alleviates thioacetamide induced liver fibrosis in mice

Jing Shao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

An interaction between MKL1, BRG1, and C/EBPβ mediates palmitate induced CRP transcription in hepatocytes

Zhiwen Fan et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2019)

添加到收藏夹

Article Multidisciplinary Sciences

BRG1 attenuates colonic inflammation and tumorigenesis through autophagy-dependent oxidative stress sequestration

Min Liu et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer

Yufeng Ding et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Brg1 regulates pro-lipogenic transcription by modulating SREBP activity in hepatocytes

Nan Li et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)

添加到收藏夹

Article Oncology

Brg1 promotes liver fibrosis via activation of hepatic stellate cells

Haijie Li et al.

EXPERIMENTAL CELL RESEARCH (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

The Origin of Fibrogenic Myofibroblasts in Fibrotic Liver

Tatiana Kisseleva

HEPATOLOGY (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Mechanisms of hepatic stellate cell activation

Takuma Tsuchida et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

添加到收藏夹

Article Cell & Tissue Engineering

In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis

Milad Rezvani et al.

CELL STEM CELL (2016)

添加到收藏夹

Article Chemistry, Medicinal

Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit

Brian S. Gerstenberger et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

添加到收藏夹

Article Oncology

The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNFMutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies

Bhavatarini Vangamudi et al.

CANCER RESEARCH (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling

Barbara H. Chaiyachati et al.

EMBO JOURNAL (2013)

添加到收藏夹

Article Gastroenterology & Hepatology

Brahma-related gene 1 bridges epigenetic regulation of proinflammatory cytokine production to steatohepatitis in mice

Wenfang Tian et al.

HEPATOLOGY (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Ingmar Mederacke et al.

NATURE COMMUNICATIONS (2013)

添加到收藏夹

Review Biochemistry & Molecular Biology

Nutrition, Epigenetics, and Metabolic Syndrome

Junjun Wang et al.

ANTIOXIDANTS & REDOX SIGNALING (2012)

添加到收藏夹

Review Pathology

Pathogenesis of Liver Fibrosis

Virginia Hernandez-Gea et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

SWI/SNF Complexes Containing Brahma or Brahma-Related Gene 1 Play Distinct Roles in Smooth Muscle Development

Min Zhang et al.

MOLECULAR AND CELLULAR BIOLOGY (2011)

添加到收藏夹

Review Gastroenterology & Hepatology

Evolving challenges in hepatic fibrosis

Scott L. Friedman

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

Senescence of activated stellate cells limits liver fibrosis

Valery Krizhanovsky et al.

CELL (2008)

添加到收藏夹

Article Immunology

A novel genetic strategy reveals unexpected roles of the Swi-Snf-like chromatin-remodeling BAF complex in thymocyte development

Anant Jani et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2008)

添加到收藏夹

Article Biochemistry & Molecular Biology

Myogenin and the SWI/SNF ATPase Brg1 maintain myogenic gene expression at different stages of skeletal myogenesis

Yasuyuki Ohkawa et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

添加到收藏夹

Article Gastroenterology & Hepatology

Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors

R Issa et al.

GUT (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.